Table 1.
Variable Differences for Abstracts Published vs Not Yet Published
| Published (%) n=327 |
Not Published (%) n=358 |
p-value | |
|---|---|---|---|
| Subject Matter | |||
| Antithrombotic Therapy | 24 (46.1) | 28(53.9) | p=0.07 |
| Bone Marrow Failure | 32 (51.6) | 30 (48.4) | |
| Erythropoiesis | 22 (47.8) | 24 (52.2) | |
| Hemostasis | 27 (33.8) | 53 (66.2) | |
| Lymphocyte | 42 (51.8) | 39 (48.2) | |
| Platelet Disorder | 51(60) | 34 (40) | |
| Sickle Cell Disease | 81(43.8) | 104(56.2) | |
| Thalassemia | 27 (54.0) | 23 (46.0) | |
| Transfusion | 21(47.7) | 23(52.3) | |
| Presentation Format | |||
| Oral | 88 (58.7) | 62 (41.3) | p<0.001* |
| Poster | 236 (46.6) | 270 (52.7) | |
| Online Publication Only # | 3 (10.3) | 26 (89.7) | |
| Science Category | |||
| Clinical | 173 (48.9) | 181 (51.1) | p=0.48 |
| Basic | 153 (46.9) | 178 (53.1) | |
| Clinical Age Group | |||
| Pediatric | 43 (46.2) | 50 (53.8) | p=0.16 |
| Adult | 64 (57.7) | 47 (42.3) | |
| Combined | 56 (46.7) | 64 (53.3) | |
| Country of Research | |||
| United States | 166 (47.4) | 184 (52.6) | p=0.93 |
| Other Countries | 160 (47.8) | 175 (52.2) | |
| Year Published | |||
| 2011 | 20 (6.1) | – | |
| 2012 | 116 (35.5) | – | |
| 2013 | 101 (30.9) | – | |
| 2014 | 54 (16.5) | – | |
| 2015 | 29 (8.9) | – | |
| 2016 | 7 (2.1) | – | |
*
p-value <0.05 considered significant
#
only sickle cell abstracts identified as published online only